Senior Management

Learn More

Board of Directors

Learn More

Clinical Advisory Board

Learn More

Scientific Advisory Board

Learn More

Bexion Milestones

Bexion milestones

Bexion Media


Bexion Pharmaceuticals Receives Study May Proceed Letter from FDA for a Phase 1b/2 Clinical Trial of BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma
September 29, 2021

FOR IMMEDIATE RELEASE Covington, KY,  29 September 2021               Bexion Pharmaceuticals, Inc. announced today that a Study May Proceed letter has been received from the US Food and Drug Administration (FDA) for the Investigational New Drug Application (IND) for BXQ-350 to initiate a Phase 1b/2 clinical trial in newly diagnosed stage 4 metastatic colorectal cancer patients. […]

read more
All Press

Cincinnati Enquirer: 8 Cincinnati biotech companies with big steps to watch in 2020
January 1, 2020

read more
Bexion In the News